{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:26:22Z","timestamp":1789701982840,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872173"],"award-info":[{"award-number":["81872173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ16H060001"],"award-info":[{"award-number":["LQ16H060001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ajpath.2024.06.015","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T02:16:32Z","timestamp":1722651392000},"page":"2163-2178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Small Nuclear Ribonucleoprotein Polypeptides B and B1 Promote Osteosarcoma Progression via Activating the Ataxia-Telangiectasia Mutated Signaling Pathway through Ribonucleotide Reductase Subunit M2"],"prefix":"10.1016","volume":"194","author":[{"given":"Yongxiang","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6734-3871","authenticated-orcid":false,"given":"Ming","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2024.06.015_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-319-07323-1_4","article-title":"Osteosarcoma","volume":"162","author":"Moore","year":"2014","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ajpath.2024.06.015_bib2","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3390\/cancers12082130","article-title":"Molecular biology of osteosarcoma","volume":"12","author":"Czarnecka","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2024.06.015_bib3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/cells10010172","article-title":"Future directions in the treatment of osteosarcoma","volume":"10","author":"Smrke","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2024.06.015_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.12.024","article-title":"Immunotherapy for osteosarcoma: fundamental mechanism, rationale, and recent breakthroughs","volume":"500","author":"Chen","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajpath.2024.06.015_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1089\/jayao.2016.0078","article-title":"Monocytes, macrophages, and osteoclasts in osteosarcoma","volume":"6","author":"Kelleher","year":"2017","journal-title":"J Adolesc Young Adult Oncol"},{"key":"10.1016\/j.ajpath.2024.06.015_bib6","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/cells9040976","article-title":"The osteosarcoma microenvironment: a complex but targetable ecosystem","volume":"9","author":"Corre","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2024.06.015_bib7","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1093\/hmg\/10.23.2661","article-title":"Origin of alternative splicing by tandem exon duplication","volume":"10","author":"Kondrashov","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2024.06.015_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng0102-13","article-title":"A genomic view of alternative splicing","volume":"30","author":"Modrek","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2024.06.015_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0092-8674(77)90294-X","article-title":"A map of cytoplasmic RNA transcripts from lytic adenovirus type 2, determined by electron microscopy of RNA:DNA hybrids","volume":"11","author":"Chow","year":"1977","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2024.06.015_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0955-0674(00)00211-8","article-title":"Spliceosomal UsnRNP biogenesis, structure and function","volume":"13","author":"Will","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.ajpath.2024.06.015_bib11","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1006\/bbrc.2001.5302","article-title":"Lupus autoantibodies recognize the product of an alternative open reading frame of SmB\/B'","volume":"285","author":"Kaufman","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2024.06.015_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/humu.22729","article-title":"Mutations in SNRPB, encoding components of the core splicing machinery, cause cerebro-costo-mandibular syndrome","volume":"36","author":"Bacrot","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ajpath.2024.06.015_bib13","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1038\/ncomms5483","article-title":"Disrupted auto-regulation of the spliceosomal gene SNRPB causes cerebro-costo-mandibular syndrome","volume":"5","author":"Lynch","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.06.015_bib14","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/ecco-jcc\/jjx019","article-title":"Identification of antibody against SNRPB, small nuclear ribonucleoprotein-associated proteins B and B', as an autoantibody marker in Crohn's disease using an immunoproteomics approach","volume":"11","author":"Wang","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ajpath.2024.06.015_bib15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.18632\/aging.202164","article-title":"SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma","volume":"13","author":"Zhan","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ajpath.2024.06.015_bib16","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/cbin.11307","article-title":"c-Myc-mediated SNRPB upregulation functions as an oncogene in hepatocellular carcinoma","volume":"44","author":"Peng","year":"2020","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.ajpath.2024.06.015_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109948","article-title":"SNRPB promotes cervical cancer progression through repressing p53 expression","volume":"125","author":"Zhu","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ajpath.2024.06.015_bib18","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1038\/s41388-023-02763-x","article-title":"The splicing factor SNRPB promotes ovarian cancer progression through regulating aberrant exon skipping of POLA1 and BRCA2","volume":"42","author":"Li","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2024.06.015_bib19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41419-019-1929-y","article-title":"SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajpath.2024.06.015_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12032-021-01502-0","article-title":"SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer","volume":"38","author":"Liu","year":"2021","journal-title":"Med Oncol"},{"key":"10.1016\/j.ajpath.2024.06.015_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13059-016-0990-4","article-title":"Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma","volume":"17","author":"Correa","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.ajpath.2024.06.015_bib22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.7150\/thno.30056","article-title":"Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer","volume":"9","author":"Deng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ajpath.2024.06.015_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1756-9966-29-85","article-title":"Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients","volume":"29","author":"Ma","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2024.06.015_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3892\/ijmm.2013.1399","article-title":"Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62\/SQSTM1","volume":"32","author":"Shen","year":"2013","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ajpath.2024.06.015_bib25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/neuonc\/noy207","article-title":"ECT2\/PSMD14\/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1","volume":"21","author":"Zhi","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ajpath.2024.06.015_bib26","article-title":"HUVEC tube-formation assay to evaluate the impact of natural products on angiogenesis","volume":"148","author":"Gentile","year":"2019","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ajpath.2024.06.015_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920974212","article-title":"PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer","volume":"12","author":"Chen","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.ajpath.2024.06.015_bib28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.canlet.2014.11.050","article-title":"miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer","volume":"357","author":"Liu","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajpath.2024.06.015_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3892\/or.2017.5735","article-title":"Anti-angiogenesis target therapy for advanced osteosarcoma (review)","volume":"38","author":"Xie","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ajpath.2024.06.015_bib30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbrc.2015.06.103","article-title":"E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2","volume":"464","author":"Fang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2024.06.015_bib31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.omtn.2019.01.001","article-title":"ERK inhibitor enhances everolimus efficacy through the attenuation of dNTP pools in renal cell carcinoma","volume":"14","author":"Zou","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ajpath.2024.06.015_bib32","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/genes12060845","article-title":"ATM: main features, signaling pathways, and its diverse roles in DNA damage response, tumor suppression, and cancer development","volume":"12","author":"Phan","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ajpath.2024.06.015_bib33","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/nm.2846","article-title":"Pathological neoangiogenesis depends on oxidative stress regulation by ATM","volume":"18","author":"Okuno","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2024.06.015_bib34","first-page":"6502","article-title":"Osteosarcoma in patients below 25 years of age: an observational study of incidence, metastasis, treatment and outcomes","volume":"16","author":"Nie","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ajpath.2024.06.015_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13018-020-1576-0","article-title":"The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis","volume":"15","author":"Zhang","year":"2020","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.ajpath.2024.06.015_bib36","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.3390\/ijms21155207","article-title":"Tumor-associated macrophages in osteosarcoma: from mechanisms to therapy","volume":"21","author":"Cersosimo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2024.06.015_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-030-12734-3_5","article-title":"Hypoxia-dependent angiogenesis and lymphangiogenesis in cancer","volume":"1136","author":"Schito","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ajpath.2024.06.015_bib38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.amjms.2018.12.004","article-title":"Angiogenesis process in osteosarcoma: an updated perspective of pathophysiology and therapeutics","volume":"357","author":"Li","year":"2019","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ajpath.2024.06.015_bib39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.biochem.75.103004.142443","article-title":"Ribonucleotide reductases","volume":"75","author":"Nordlund","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.ajpath.2024.06.015_bib40","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.18632\/aging.202292","article-title":"High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma","volume":"13","author":"Jin","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ajpath.2024.06.015_bib41","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.7150\/jca.47895","article-title":"Independent prognostic implications of RRM2 in lung adenocarcinoma","volume":"11","author":"Ma","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.ajpath.2024.06.015_bib42","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s12935-020-01689-8","article-title":"RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer","volume":"20","author":"Yang","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.ajpath.2024.06.015_bib43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/odi.13540","article-title":"Overexpression of RRM2 is related to poor prognosis in oral squamous cell carcinoma","volume":"27","author":"Wang","year":"2021","journal-title":"Oral Dis"},{"key":"10.1016\/j.ajpath.2024.06.015_bib44","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41388-020-01552-0","article-title":"The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors","volume":"40","author":"Goss","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2024.06.015_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.onc.1201319","article-title":"Recombinant ATM protein complements the cellular A-T phenotype","volume":"15","author":"Ziv","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2024.06.015_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8850708","article-title":"Ataxia telangiectasia mutated protein kinase: a potential master puppeteer of oxidative stress-induced metabolic recycling","volume":"2021","author":"Blignaut","year":"2021","journal-title":"Oxid Med Cell Longev"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024002803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024002803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T20:23:32Z","timestamp":1762028612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944024002803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0002944024002803"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.06.015","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small Nuclear Ribonucleoprotein Polypeptides B and B1 Promote Osteosarcoma Progression via Activating the Ataxia-Telangiectasia Mutated Signaling Pathway through Ribonucleotide Reductase Subunit M2","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}